OVERVIEW
The global market for creatinine assay kits is projected to hit USD 455 million by 2025, increasing over the forecast period at a CAGR of 4.56%. The growth of this market is primarily driven by the growing incidence of renal disorders, the rising incidence of other chronic disorders affecting renal function, increased knowledge and acceptance of preventive health care, rapid growth of the geriatric population, and developments in biomedical research related to kidney disorders and funding availability.
TABLE OF CONTENT
1 Global Creatinine Assay Kits Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Creatinine Assay Kits Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Creatinine Assay Kits Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Creatinine Assay Kits Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Creatinine Assay Kits Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Creatinine Assay Kits Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Creatinine Assay Kits Market – By Type (Market Size – & million/billion)
8.1 Jaffe’s Kinetic Test Kits
8.2 Creatinine-PAP Test Kits
8.3 ELISA Test Kits
9 Global Creatinine Assay Kits Market – By Type of Sample
9.1 Blood/Serum
9.2 Urine
9.3 Other
10 Global Creatinine Assay Kits Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Creatinine Assay Kits Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Creatinine Assay Kits Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Thermo Fisher Scientific Inc.
12.3 Merck KGaA
12.4 Abcam PLC
12.5 Abbott Laboratories
12.6 Quidel Corporation
12.7 Crystal Chem Inc.
12.8 Cell Biolabs Inc.
12.9 Genway Biotech
12.10 Enzo Life Sciences, Inc.
12.11 Cayman Chemical
12.12 Company 11 & more
13 Global Creatinine Assay Kits Market – Appendix
13.1 Sources
13.2 Abbreviations
